21/10/2026
Could programming stem cells help change the future of diabetes research? π§¬π©Ί
Syntax Bio has reported that its Cellgorithm platform can guide human stem cells towards insulin-producing pancreatic beta cells in just four days. The approach uses carefully sequenced genetic instructions to direct how cells develop, potentially helping researchers produce specialised cells more quickly and consistently. The findings are still at the research stage, but faster cell programming could become valuable in the development of future regenerative therapies for type 1 diabetes.